Introduction
============

Atrial fibrillation (AF) is the most common type of arrhythmia. It is associated with several long-term risks, including increased risks of stroke, heart failure, and all-cause mortality \[[@b1-kjtcv-51-266]\]. Performing a maze procedure for the treatment of AF concomitantly with other cardiac procedures can prolong the operation time, cardiopulmonary bypass (CPB) time, and cardiac arrest time. In addition, surgical ablation increases the risk of postoperative bleeding and the need for permanent pacemaker (PPM) insertion \[[@b2-kjtcv-51-266],[@b3-kjtcv-51-266]\]. However, the substantial benefits from regaining sinus rhythm and atrial contractility warrant the potential risks \[[@b3-kjtcv-51-266]\]. Thus, performing surgical ablation concomitantly with other cardiac procedures is recommended in patients with AF \[[@b4-kjtcv-51-266]\]. Although the original 'cut-and-sew' Cox maze III procedure had higher efficacy, it was widely substituted with ablation using radiofrequency and cryothermal energy to overcome its technical complexity and to reduce the risk of postoperative bleeding \[[@b5-kjtcv-51-266]--[@b7-kjtcv-51-266]\]. However, few studies have compared the efficacy of radiofrequency ablation with that of cryoablation. The purpose of this study was to compare radiofrequency ablation and cryoablation with regard to clinical outcomes, including overall survival, major cardiovascular and cerebrovascular event (MACCE)-free survival, sinus rhythm restoration, atrial contractility, and overall cardiac function.

Methods
=======

This study was approved by the Institutional Review Board of Seoul National University Bundang Hospital, which waived the need for informed consent (IRB approval no., B-1711-432-107).

1) Study population
-------------------

A total of 239 consecutive patients who underwent surgical ablation at our institution with or without other cardiac procedures between August 2003 and December 2016 were included. Patients were divided into 2 groups according to the device utilized as an energy source for surgical ablation. Radiofrequency ablators were either monopolar (Cardioblate; Medtronic Inc., Minneapolis, MN, USA) or bipolar (Cardioblate, Medtronic Inc.) and were used in 140 patients (group A), whereas cryoablators (\[Cardioblate, Medtronic Inc.\] or \[cryoICE; AtriCure Inc., Mason, OH, USA\]) were used in 99 patients (group B). The preoperative characteristics of the patients are described in [Table 1](#t1-kjtcv-51-266){ref-type="table"}. A history of previous cardiac surgery was more common in group A patients. Most of the patients had persistent AF, except for 7 (2.9%) who had paroxysmal AF.

2) Operative strategy and surgical ablation lesion set
------------------------------------------------------

The operative characteristics of the patients are described in [Table 2](#t2-kjtcv-51-266){ref-type="table"}. Replacement or repair of the valve was most frequently combined with surgical ablation. Concomitant coronary artery bypass grafting was more common in group A patients. Decisions on performing surgical ablation, the energy source, and the lesion set were made at the surgeon's discretion. Radiofrequency ablators were available and used from the beginning of the study period, whereas cryoablators were used starting in November 2009. The bilateral lesion sets did not change based on the choice of ablator. Radiofrequency ablation lesion sets were replaced by cryoablation lesion sets. The right atrial auricle was resected. A longitudinal line between the superior and inferior vena cava, a vertical line at the inferior vena cava, and an atrial septal line were cut and sewn. The lines of the tricuspid annulus, coronary sinus, pulmonary vein box, mitral annulus, left atrial auricle, and left atrial auricle to the mitral valve were ablated. When surgical ablation was conducted under CPB, the bypass and aortic cross-clamp time were recorded and compared between the patients in the 2 groups.

3) Clinical outcomes and echocardiography findings
--------------------------------------------------

Operative and anesthetic records of heart rhythm were reviewed at the end of each operation. The rhythm was assessed using a 12-lead electrocardiogram (ECG) or a 24-hour Holter monitor and compared between the groups at discharge and at a 1-year follow-up. Additionally, echocardiographic (echoCG) data were collected at discharge and at the 1-year follow-up. Measurements of the left ventricle ejection fraction (LVEF), left atrium anteroposterior dimension (LAD), and left ventricle end-diastolic dimension (LVEDD) were recorded. Atrial contractility was assessed by the presence of the A-wave (1: positive velocity from the left atrium to left ventricle was observed using Doppler echoCG after observing the p-wave on ECG or 2: atrial contraction was observed using tissue Doppler echoCG after observing the p-wave on ECG). Survival data were collected from outpatient clinical visits, telephone calls, or records of the Korean Ministry of the Interior and Safety. A MACCE was defined as the occurrence of any of the following: all-cause death, myocardial infarction, cardiac reoperation/reintervention, stroke, transient ischemia attack, or readmission for congestive heart failure.

4) Statistical analysis
-----------------------

IBM SPSS Statistics ver. 22.0.0 (IBM Corp., Armonk, NY, USA) was used for statistical analyses. Continuous variables are presented as mean±standard deviation. The Student t-test was used to compare the results of continuous variables. The results for categorical variables are presented as frequency (%), and categorical variables were analyzed using the chi-square test or the Fisher exact test. Prognostic factors for atrial contractility were evaluated using multivariate logistic regression analysis. All p-values \<0.05 were considered to indicate statistical significance. Survival data were depicted using a Kaplan-Meier curve and tested using the log-rank test.

Results
=======

1) Sinus conversion and restoration of atrial contractility
-----------------------------------------------------------

Apart from 1 case of early death in group B, all patients had records of their immediate postoperative rhythm status and ECG before discharge. In the immediate postoperative period, the group A patients had a higher rate of AF, while the group B patients had a higher rate of abnormal sinus rhythm ([Table 3](#t3-kjtcv-51-266){ref-type="table"}). At discharge, the group A patients had a higher rate of AF, whereas the group B patients had a higher rate of restoration of atrial contractility, which was less than half that of sinus conversion.

When rhythm and atrial contractility were compared at the 1-year follow-up using the available ECG and echoCG data, sinus rhythm and atrial contractility were more frequently found in the group B patients; however, no statistical significance was observed. In addition to atrial contractility, the LVEF was significantly higher in the group B patients, and was comparable with the preoperative data. The PPM insertion rate was higher in the group A patients. However, these differences were not statistically significant.

2) Predictive factors for restoration of atrial contractility
-------------------------------------------------------------

To assess the impact of the energy source used in the maze procedure on atrial contractility, logistic regression analysis was performed, with possible confounding factors including LAD, surgical ablation lesion set, and persistence of AF ([Table 4](#t4-kjtcv-51-266){ref-type="table"}). At discharge, it was found that the use of a cryoablator rather than a radiofrequency ablator contributed to the restoration of atrial contractility, which remained consistent at the 1-year follow-up ([Table 5](#t5-kjtcv-51-266){ref-type="table"}). Moreover, a smaller LAD was a predictive factor for restoration of atrial contractility at discharge ([Table 4](#t4-kjtcv-51-266){ref-type="table"}).

3) Survival analysis according to the energy source
---------------------------------------------------

There were 3 cases of early (30-day) mortality in both group A (3 of 140 \[2.1%\]) and group B (3 of 99 \[3.0%\]). At a median follow-up duration of 36 months (group A: 76.9 months; interquartile range \[IQR\], 33.2--111.5 months; group B: 18.6 months; IQR, 10.0--28.6 months), there were 44 overall mortalities. There was no significant difference in overall survival between the 2 groups ([Fig. 1A](#f1-kjtcv-51-266){ref-type="fig"}). The 1-year, 3-year, and 5-year overall survival rates were 91.4%±2.4%, 87.5%±2.8%, and 80.1%±3.6% in group A, respectively, and 95.9%±2.0%, 92.1%±2.9%, and 92.1%± 2.9% in group B, respectively.

MACCE-free survival was not significantly different between the 2 groups ([Fig. 1B](#f1-kjtcv-51-266){ref-type="fig"}). In group A, the 1-year, 3-year, and 5-year MACCE-free survival rates were 91.4%±2.4%, 80.2%±3.4%, and 70.3%±4.0%, respectively, while in group B, they were 92.8%±2.6%, 78.9%±4.3%, and 70.9%±5.6%, respectively.

Discussion
==========

1) Sinus conversion
-------------------

Both radiofrequency ablation and cryoablation are known to be safe and effective for restoring sinus rhythm in AF patients \[[@b5-kjtcv-51-266]--[@b12-kjtcv-51-266]\]. The sinus rhythm restoration rate has been reported to be between 61% and 85% \[[@b6-kjtcv-51-266]--[@b13-kjtcv-51-266]\], which is slightly lower than that reported for the standard 'cut-and-sew' Cox maze III procedure \[[@b5-kjtcv-51-266]--[@b12-kjtcv-51-266]\]. However, it has been argued that the restoration rate of the standard Cox-maze III has been overestimated, with the real restoration rate being approximately 80% \[[@b13-kjtcv-51-266]\].

Few studies have compared the results of the maze procedure according to the energy source used \[[@b8-kjtcv-51-266],[@b9-kjtcv-51-266],[@b12-kjtcv-51-266]\]. In the current study, the frequency of sinus rhythm was higher in the cryoablation group, whereas that of AF was higher in the radiofrequency ablation group at discharge. Similar to previous studies, the frequency of sinus rhythm at the 1-year follow-up increased in both groups \[[@b14-kjtcv-51-266]\]; however, this difference was not statistically significant.

2) Atrial contractility
-----------------------

The rate of restoration of atrial contractility, which has been reported to be 23%--76% \[[@b10-kjtcv-51-266],[@b15-kjtcv-51-266],[@b16-kjtcv-51-266]\], was found to be approximately 20% lower than that of sinus rhythm \[[@b9-kjtcv-51-266],[@b14-kjtcv-51-266]--[@b16-kjtcv-51-266]\]. Theoretically, because of the atrial 'kick,' restoration of atrial contractility may be associated with increased ventricular preload, increased LVEF, reduced LAD, and reduced risk of stroke. However, its predictors have not yet been established \[[@b15-kjtcv-51-266],[@b16-kjtcv-51-266]\]. In the current study, atiral contractility restoration rate at discharge was significantly higher in the cryoablation group than in the radiofrequency ablation group. And, the rate was associated with smaller preoperative LAD. In contrast, the only predictor of restoration of atrial contractility at the 1-year follow-up was cryoablation.

3) Clinical outcomes
--------------------

There was no statistically significant difference in the overall survival and MACCE-free survival (including stroke) rates between the 2 groups. Owing to the restoration of atrial contractility, which was shown to be associated with the energy source used, the incidence of stroke or readmission for heart failure was expected to be lower in group B. However, because of the small number of patients and the short follow-up period, those clinical outcomes were not found to be significantly different between the 2 groups.

4) Echocardiographic
--------------------

There were no significant differences in preoperative echoCG parameters between the 2 groups, while the group A patients showed higher LVEF, smaller LAD, and smaller LVEDD at the 1-year follow-up than the group B patients. The results of this study may be limited due to loss to follow-up and variations in the echoCG follow-up period. Accordingly, these outcomes should be interpreted with caution. However, these results imply that restoration of atrial contractility may be associated with good left heart function.

5) Permanent pacemaker insertion
--------------------------------

According to the literature, the incidence of PPM insertion after the maze procedure is 7%--11% \[[@b2-kjtcv-51-266],[@b5-kjtcv-51-266]\]. In this study, the incidence of PPM insertion was 5.7% in group A and 2.0% in group B; these rates are consistent with those reported in previous studies \[[@b2-kjtcv-51-266],[@b5-kjtcv-51-266]\].

6) Limitation
-------------

This study was a retrospective single-center study. This center started performing surgical ablation in 2004. The energy sources and equipment used in surgical ablation have changed over time. Atrial contractility was only assessed by the presence of the A-wave in trans-mitral flow, rather than the A-wave in trans-tricuspid flow. In some studies, the clinical manifestations differed according to left and right atrial contractility \[[@b10-kjtcv-51-266],[@b15-kjtcv-51-266],[@b16-kjtcv-51-266]\]. In addition, although surgical ablation is known to affect the functional class of patients \[[@b3-kjtcv-51-266]\], our study did not include functional class assessments.

7) Conclusion
-------------

In the maze procedure, compared with radiofrequency ablation, cryoablation may be associated with improved atrial contractility recovery and left ventricular function, as observed on echoCG. However, no relationship between the energy source used in the maze procedure and overall or MACCE-free survival was observed.
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###### 

Preoperative characteristics

  Characteristic                                 Group A (n=140)   Group B (n=99)   p-value
  ---------------------------------------------- ----------------- ---------------- ---------
  Demographics                                                                      
   Age (yr)                                      60.5±12.2         61.7±10.9        0.420
   Male                                          67 (47.9)         42 (42.4)        0.406
   Smoker                                                                           0.257
    Never smoker                                 83 (59.3)         67 (67.7)        
    Ex-smoker                                    33 (23.6)         22 (22.2)        
    Current smoker                               24 (17.1)         10 (10.1)        
   Diabetes                                      26 (18.6)         11 (11.1)        0.116
   Hypertension                                  46 (32.9)         43 (43.4)        0.096
   Dyslipidemia                                  9 (6.4)           12 (12.1)        0.126
   History of stroke                             17 (12.1)         12 (12.1)        0.996
   Chronic kidney disease                        5 (3.6)           3 (3.0)          0.819
   Acute renal failure                           1 (0.7)           1 (1.0)          \>0.999
   Chronic obstructive pulmonary disease         13 (9.3)          9 (9.1)          0.959
   Previous cardiac surgery                      8 (5.7)           0                0.022
   Infective endocarditis                        4 (2.9)           3 (3.0)          0.999
  Type of atrial fibrillation                                                       0.999
   Persistent                                    136 (97.1)        96 (97.0)        
   Paroxysmal                                    4 (2.9)           3 (3.0)          
  Preoperative echocardiography                                                     
   Left ventricle ejection fraction (%)          55.0±9.4          56.2±10.4        0.338
   Left atrial dimension (mm)                    55.8±10.0         55.4±9.8         0.775
   Left ventricle end-diastolic dimension (mm)   54.6±10.8         52.47±9.7        0.119

Values are presented as mean±standard deviation for continuous variables and frequency (%) for categorical variables.

###### 

Operative characteristics and maze lesion set

  Characteristic                                        Group A (n=140)   Group B (n=99)   p-value
  ----------------------------------------------------- ----------------- ---------------- ---------
  Urgency/emergency operation                                                              0.037
   Elective                                             131 (93.6)        99 (100.0)       
   Urgency                                              8 (5.7)           0                
   Emergency                                            1 (0.7)           0                
  Concomitant procedure                                                                    
   Valve                                                122 (87.1)        86 (86.9)        0.950
   Coronary artery bypass graft surgery                 17 (12.1)         2 (2.0)          0.004
   Aorta                                                11 (8.0)          5 (5.1)          0.377
   Other[a)](#tfn3-kjtcv-51-266){ref-type="table-fn"}   13 (9.3)          9 (9.1)          0.959
  Cardiopulmonary bypass time (min)                     157.4±59.6        160.7±44.4       0.679
  Aortic cross-clamping time (min)                      120.6±48.9        129.4±143.6      0.551
  Ablation lesion set                                                                      0.011
   Bilateral                                            123 (87.9)        98 (99.0)        
   Right-side                                           10 (7.1)          0                
   Left-side                                            4 (2.9)           0                
   Pulmonary vein isolation                             3 (2.1)           1 (1.0)          

Values are presented as frequency (%) for categorical variables or mean±standard deviation for continuous variables.

Repair of atrial septal defect, repair of ventricular septal defect, and tumor excision.

###### 

Sinus conversion and restoration of atrial contractility

  Variable                                                Group A      Group B     p-value
  ------------------------------------------------------- ------------ ----------- ---------
  Immediate postoperative rhythm                                                   \<0.001
   Atrial fibrillation                                    30 (21.4)    8 (8.2)     
   Sinus rhythm                                           100 (71.4)   66 (67.3)   
   Sick sinus syndrome                                    10 (7.1)     24 (24.5)   
  Rhythm at discharge                                                              0.002
   Atrial fibrillation                                    69 (49.3)    27 (27.6)   
   Sinus rhythm                                           65 (46.4)    68 (69.4)   
   Sick sinus syndrome                                    6 (4.3)      3 (3.1)     
  Atrial contractility at discharge                       14 (10.8)    20 (20.4)   0.043
  Rhythm at 1 year                                                                 0.186
   Atrial fibrillation                                    31 (30.7)    12 (19.7)   
   Sinus rhythm                                           66 (65.3)    48 (78.7)   
   Sick sinus syndrome                                    4 (4.0)      1 (1.6)     
  Atrial contractility at 1 year                          19 (32.2)    21 (48.8)   0.089
  Left ventricle ejection fraction at 1 year (%)          53.1±11.5    59.1±6.3    0.001
  Left atrial dimension at 1 year (mm)                    48.3±8.5     52.0±17.7   0.164
  Left ventricle end-diastolic dimension at 1 year (mm)   50.4±7.5     49±5.9      0.298
  Permanent pacemaker insertion                           8 (5.7)      2 (2.0)     0.202

Values are presented as frequency (%) for categorical variables or mean±standard deviation for continuous variables.

###### 

Predictive factor analysis for atrial contractility at discharge

  Variable                                           Odds ratio (95% confidence interval)   p-value
  -------------------------------------------------- -------------------------------------- ---------
  Cryoablation (vs. radiofrequency)                  2.603 (1.151--5.885)                   0.022
  Preoperative left atrial dimension                 0.950 (0.910--0.991)                   0.017
  Bilateral ablation lesion set                      0.550 (0.118--2.574)                   0.448
  Paroxysmal atrial fibrillation (vs. persistent)    0.544 (0.056--5.332)                   0.602
  Concomitant coronary artery bypass graft surgery   1.381 (0.306--6.236)                   0.675

Multivariate logistic regression analysis.

###### 

Predictive factor analysis for atrial contractility at 1-year follow-up

  Variable                                          Odds ratio (95% confidence interval)   p-value
  ------------------------------------------------- -------------------------------------- ---------
  Cryoablation (vs. radiofrequency)                 2.540 (1.063--6.071)                   0.036
  Preoperative left atrial dimension                0.964 (0.925--1.005)                   0.084
  Bilateral ablation lesion set                     0.350 (0.041--2.986)                   0.337
  Paroxysmal atrial fibrillation (vs. persistent)   2.886 (0.226--36.796)                  0.414
  Concomitant coronary artery bypass graft          2.105 (0.127--34.834)                  0.603

Multivariate logistic regression analysis.
